Immunocore Holdings plc
IMCR
$37.88
$1.714.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 103.69M | 97.96M | 93.88M | 84.05M | 80.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 103.69M | 97.96M | 93.88M | 84.05M | 80.25M |
| Cost of Revenue | 71.09M | 70.05M | 831.00K | -153.20M | 53.22M |
| Gross Profit | 32.61M | 27.92M | 93.05M | 237.25M | 27.03M |
| SG&A Expenses | 39.78M | 42.79M | 40.20M | 42.32M | 35.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -18.05M | -- |
| Total Operating Expenses | 110.86M | 112.84M | 97.50M | 85.45M | 88.75M |
| Operating Income | -7.17M | -14.88M | -3.62M | -1.40M | -8.50M |
| Income Before Tax | 304.00K | -9.69M | 6.08M | -24.82M | 6.09M |
| Income Tax Expenses | 481.00K | 606.00K | 1.06M | -1.05M | -2.64M |
| Earnings from Continuing Operations | -177.00K | -10.30M | 5.02M | -23.77M | 8.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -177.00K | -10.30M | 5.02M | -23.77M | 8.74M |
| EBIT | -7.17M | -14.88M | -3.62M | -1.40M | -8.50M |
| EBITDA | -6.37M | -14.10M | -2.76M | -235.00K | -7.47M |
| EPS Basic | 0.00 | -0.20 | 0.10 | -0.48 | 0.17 |
| Normalized Basic EPS | 0.00 | -0.12 | 0.01 | -0.26 | 0.08 |
| EPS Diluted | 0.00 | -0.20 | 0.10 | -0.48 | 0.17 |
| Normalized Diluted EPS | 0.00 | -0.12 | 0.01 | -0.26 | 0.07 |
| Average Basic Shares Outstanding | 50.40M | 50.29M | 50.09M | 50.05M | 50.02M |
| Average Diluted Shares Outstanding | 50.40M | 50.29M | 51.95M | 50.05M | 52.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |